Publication

Article

Supplements and Featured Publications

Measuring Persistency with Drug Therapy in Glaucoma Management
Volume8
Issue 10 Suppl

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo